Fate Therapeutics Inc (NASDAQ:FATE)

37.18
Delayed Data
As of Jan 21
 -1.12 / -2.92%
Today’s Change
37.05
Today|||52-Week Range
118.14
-36.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-30.0M-33.5M-43.0M-66.6M
 
 
 
 
 
Depreciation687.0K881.0K971.0K1.2M
 
 
 
 
 
Total Other Cash Flow10.5M1.6M3.0M25.0M
 
 
 
 
 
Funds From Operations-18.8M-31.0M-39.0M-40.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-370.0K-1.2M-2.1M-1.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-18.4M-29.8M-36.9M-38.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-19.7M-40.0M-55.7M
 
 
 
 
Decrease In Investments0.0016.0M31.5M57.5M
 
 
 
 
Capital Expenditures-1.5M-457.0K-1.7M-2.3M
 
 
 
 
 
Fixed Asset Disposal0.0018.0K0.000.00
 
 
Net Cash Flow Investing-1.5M-4.1M-10.2M-463.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.0015.0M0.00
 
 
Long Term Debt Reduction-1.5M-7.7M-10.8M0.00
 
 
 
 
Net Proceeds Stock Sale37.1M65.4M43.2M137.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.003.5M
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing35.6M57.7M47.4M140.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash15.7M23.8M343.0K101.7M